Failure of cidofovir in HIV-associated multicentric Castleman disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2004-01-0158PMID 15155471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

  2004cited by this paper
• High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

  2002cited by this paper
• Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS.

  2001cited by this paper
• Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

  2001cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

  2000cited by this paper
• Identification and Rapid Quantification of Early- and Late-Lytic Human Herpesvirus 8 Infection in Single Cells by Flow Cytometric Analysis: Characterization of Antiherpesvirus Agents

  1999cited by this paper
• Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

  1999cited by this paper
• Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

  1997cited by this paper
• Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

  1997cited by this paper
• In vitro antiviral drug sensitivity of the Kaposi's sarcoma‐associated herpesvirus

  1997cited by this paper
• Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

  1996cited by this paper

• The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy

  2025cites this paper
• Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma

  2022influential citation
• Castleman disease

  2021cites this paper
• KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV

  2021cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• Unexplained Diffuse Lymphadenopathy in a Patient With HIV

  2020cites this paper
• Lymphoproliferative Disorders of the Lung

  2017cites this paper
• Practical Management of Castleman's Disease

  2016cites this paper
• Update and new approaches in the treatment of Castleman disease

  2016cites this paper
• The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients

  2016cites this paper
• HIV: Treatment and Comorbidity

  2016cites this paper
• Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome

  2015cites this paper
• Hyaline-vascular Multicentric Castleman's Disease in an immunocompetent patient

  2015cites this paper
• [Hyaline-vascular Multicentric Castleman's Disease in an immunocompetent patient].

  2015cites this paper
• Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy

  2015cites this paper
• Diagnosis and management of Castleman disease.

  2014cites this paper
• KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

  2014cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus: Epidemiology, Biological Characteristics and Pathogenesis

  2014cites this paper
• Targeted treatment of HHV-8-associated multicentric Castleman's disease

  2013cites this paper
• Pulmonary manifestations of human herpesvirus-8 during HIV infection

  2013cites this paper
• Multicentric Castleman’s Disease: A Challenging Diagnosis

  2013cites this paper
• Chapter 35 – HIV-associated malignancies

  2012cites this paper
• [Pulmonary involvement due to HHV-8 virus during the course of HIV infection].

  2012cites this paper
• Castleman disease

  2012cites this paper
• Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein

  2012cites this paper
• Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.

  2012cites this paper
• Atteintes pulmonaires liées au virus HHV-8 au cours de l’infection VIH

  2012cites this paper
• Virus-host cell interplay in the pathogenesis of Kaposi's sarcoma herpesvirus

  2012cites this paper
• Rhadinoviruses: KSHV and Associated Malignancies

  2012cites this paper
• Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

  2012cites this paper
• Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease.

  2011cites this paper
• Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment

  2011cites this paper
• Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.

  2011cites this paper
• High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

  2011cites this paper
• Castleman's disease: from basic mechanisms to molecular therapeutics.

  2011cites this paper
• HIV-associated multicentric Castleman disease

  2011cites this paper
• Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

  2011cites this paper
• To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration

  2010cites this paper
• How I treat HIV-associated multicentric Castleman disease.

  2010cites this paper
• Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.

  2010cites this paper
• Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant)

  2010cites this paper
• Complete remission in a patient with human herpes virus-8 negative multicentric Castleman disease using CHOP chemotherapy.

  2009cites this paper
• HIV-associated multicentric Castleman disease

  2009cites this paper
• Prevention and treatment of KSHV-associated diseases with antiviral drugs

  2008cites this paper
• New approaches to the treatment of human herpesvirus 8‐associated disease

  2008cites this paper
• Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

  2008cites this paper
• CHAPTER 40 – HIV-associated Neoplasia

  2008cites this paper
• Multicentric Castleman's disease masquerading as HIV-related lymphoma.

  2007cites this paper
• Multicentric Castleman disease: Use of HHV8 viral load monitoring and positron emission tomography during follow-up

  2007cites this paper
• Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.

  2007cites this paper
• Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

  2007cites this paper
• Castleman's disease and retroviral therapy.

  2007cites this paper
• The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.

  2007cites this paper
• The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma.

  2007cites this paper
• [A case of HIV-1 and HHV-8-associated Castleman disease with a relapsing high fever and lymphoadenopathy].

  2006cites this paper
• OPTIMIZATION OF A SEROLOGICAL ASSAY SYSTEM FOR ESTABLISHING INFECTION OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS (KSHV) IN MULTIPLE POPULATIONS AT VARYING LEVELS OF RISK

  2006influential citation
• AIDS-related lymphoproliferative disease.

  2006cites this paper
• The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy

  2006cites this paper
• Multicentric Castleman's disease in HIV infection

  2006cites this paper
• Review in translational hematology AIDS-related lymphoproliferative disease

  2005cites this paper
• The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care

  2005cites this paper
• Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena

  2005cites this paper